Re:Illinois governor signs law capping insulin costs at $100...
by mumblemumble on Wednesday January 29, 2020 @11:42AM
(#22182539)
This analysis you link leaves plenty of room for either or both stories to be correct.
Perhaps the marketing and R&D departments compete internally for budget. They certainly do at every other company I've worked at.
And drug marketing is peculiar. One would expect demand to be largely inelastic, so it's odd to see marketing spend on par with that of soft drinks in the industry. Nor can we safely assume that whatever portion of demand is driven by marketing is beneficial from a public health perspective, given that overtreatment is known to be a serious problem in the USA, and that a significant motivator for overtreatment is patient pressure on health care providers.
Perhaps the marketing and R&D departments compete internally for budget. They certainly do at every other company I've worked at.
And drug marketing is peculiar. One would expect demand to be largely inelastic, so it's odd to see marketing spend on par with that of soft drinks in the industry. Nor can we safely assume that whatever portion of demand is driven by marketing is beneficial from a public health perspective, given that overtreatment is known to be a serious problem in the USA, and that a significant motivator for overtreatment is patient pressure on health care providers.